Skip to main content
Maged Ghaly, MD, Radiation Oncology, New Hyde Park, NY, Glen Cove Hospital

MagedMofiedGhalyMD

Radiation Oncology New Hyde Park, NY

Central Nervous System Cancer, Gastrointestinal Cancer, Head & Neck

Assistant Professor, Radiation Medicine, Hofstra North Shore-LIJ

Dr. Ghaly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ghaly's full profile

Already have an account?

  • Office

    450 Lakeville Road
    Entrance A- Radiation Medicine
    New Hyde Park, NY 11042
    Phone+1 855-927-6622
    Fax+1 516-470-8445
  • Is this information wrong?

Education & Training

  • New York-Presbyterian Brooklyn Methodist Hospital
    New York-Presbyterian Brooklyn Methodist HospitalResidency, Radiation Oncology, 1998 - 2002
  • New York-Presbyterian Brooklyn Methodist Hospital
    New York-Presbyterian Brooklyn Methodist HospitalInternship, Internal Medicine, 1997 - 1998
  • Cairo University School of Medicine
    Cairo University School of MedicineClass of 1992

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2025
  • PA State Medical License
    PA State Medical License 2001 - 2001
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2014
  • Newsday - Top Doctors on Long Island Castle Connolly, 2012-2014

Publications & Presentations

PubMed

Press Mentions

  • Medical Grade Cement May Help Cancer Patients Whose Disease Has Spread to the Spine
    Medical Grade Cement May Help Cancer Patients Whose Disease Has Spread to the SpineApril 18th, 2017
  • Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in Its Core Focus Area of Cancer Supportive Care
    Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in Its Core Focus Area of Cancer Supportive CareApril 19th, 2024

Hospital Affiliations